{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:33:55Z","timestamp":1779878035363,"version":"3.53.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1054\/blre.2000.0132","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:24Z","timestamp":1032447324000},"page":"121-129","source":"Crossref","is-referenced-by-count":35,"title":["Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia"],"prefix":"10.1054","volume":"14","author":[{"given":"R.A.","family":"Mesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2000.0132_RF1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2141.1978.tb01048.x","article-title":"The pathogenesis of myeloproliferative syndromes","volume":"38","author":"Adamson","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes (editorial)","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0025-7125(16)32287-8","article-title":"The spectrum of myeloproliferative disorders","volume":"57","author":"Gilbert","year":"1973","journal-title":"Med Clin North Am"},{"key":"10.1054\/blre.2000.0132_RF4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0132_RF5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1359-6101(96)00047-0","article-title":"Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR\/ABL","volume":"8","author":"Sattler","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1054\/blre.2000.0132_RF6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1054\/blre.2000.0132_RF7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1988.tb00861.x","article-title":"The spleen and pooling of blood cells","volume":"41","author":"Wadenvik","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2000.0132_RF8","series-title":"Surgical care II","first-page":"118","article-title":"Physiology of the spleen and the role of splenectomy in hematologic disorders","author":"Schwartz","year":"1985"},{"key":"10.1054\/blre.2000.0132_RF9","series-title":"Wintrobe\u2019s clinical hematology, 10th edn","first-page":"1969","article-title":"Disorders of the spleen","author":"Chapman","year":"1999"},{"key":"10.1054\/blre.2000.0132_RF10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2559.1994.tb00516.x","article-title":"Extramedullary haemopoiesis in fetal and adult human spleen: a quantitative immunohistological study","volume":"24","author":"Wilkins","year":"1994","journal-title":"Histopathology"},{"key":"10.1054\/blre.2000.0132_RF11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0308-2261(21)00398-2","article-title":"The spleen in myeloproliferative disorders","volume":"12","author":"Goldman","year":"1983","journal-title":"Clin Haematol"},{"key":"10.1054\/blre.2000.0132_RF12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0268-960X(97)90022-9","article-title":"Idiopathic myelofibrosis: pathogenesis, natural history and management","volume":"11","author":"Reilly","year":"1997","journal-title":"Blood Rev"},{"key":"10.1054\/blre.2000.0132_RF13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02465093","article-title":"Indications for and results of splenectomy in different hematological disorders","volume":"382","author":"Bohner","year":"1997","journal-title":"Langenbecks Arch Chir"},{"key":"10.1054\/blre.2000.0132_RF14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0132_RF15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"10.1054\/blre.2000.0132_RF16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0609.1987.tb01452.x","article-title":"Splenic function in chronic myelogenous leukemia","volume":"39","author":"Covas","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2000.0132_RF17","first-page":"507","article-title":"Splenectomy in chronic non-leukemic myeloid splenomegaly with report of case with osteosclerosis","volume":"92","author":"Bukh","year":"1945","journal-title":"Acta Chir Scand"},{"key":"10.1054\/blre.2000.0132_RF18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.1974.tb00240.x","article-title":"Cytogenetic evidence for splenic origin of blastic transformation in chronic myeloid leukaemia","volume":"13","author":"Mitelman","year":"1974","journal-title":"Scand J Haematol"},{"key":"10.1054\/blre.2000.0132_RF19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bmj.2.5968.421","article-title":"Removal of abnormal clone of leukaemic cells by splenectomy","volume":"2","author":"Gomez","year":"1975","journal-title":"BMJ"},{"key":"10.1054\/blre.2000.0132_RF20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.1.5951.175","article-title":"Chronic granulocytic leukaemia: effect of elective splenectomy on the course of disease","volume":"1","author":"Spiers","year":"1975","journal-title":"BMJ"},{"key":"10.1054\/blre.2000.0132_RF21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1097-0142(19841101)54:9<1977::AID-CNCR2820540932>3.0.CO;2-V","article-title":"Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group study","volume":"54","author":"Hester","year":"1984","journal-title":"Cancer"},{"key":"10.1054\/blre.2000.0132_RF22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1200\/JCO.1985.3.2.192","article-title":"Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogeneous leukemia","volume":"3","author":"Kantarjian","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1054\/blre.2000.0132_RF23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(19840715)54:2<333::AID-CNCR2820540226>3.0.CO;2-1","volume":"54","year":"1984","journal-title":"Cancer"},{"key":"10.1054\/blre.2000.0132_RF24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0039-6060(97)90259-2","article-title":"Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience","volume":"122","author":"Bouvet","year":"1997","journal-title":"Surgery"},{"key":"10.1054\/blre.2000.0132_RF25","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/1097-0142(19841201)54:11<2456::AID-CNCR2820541124>3.0.CO;2-6","article-title":"Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase","volume":"54","author":"Sadamori","year":"1984","journal-title":"Cancer"},{"key":"10.1054\/blre.2000.0132_RF26","first-page":"537","article-title":"Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome","volume":"17","author":"Enright","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1054\/blre.2000.0132_RF27","first-page":"147","article-title":"No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study","volume":"10","author":"Gratwohl","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1054\/blre.2000.0132_RF28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajh.2830220308","article-title":"The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation","volume":"22","author":"Banaji","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2000.0132_RF29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.1984.tb03974.x","article-title":"Haematological reconstitution and severity of graft-versus-host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy","volume":"56","author":"Baughan","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(85)91566-1","article-title":"Effect of splenectomy before bone-marrow transplantation on survival in chronic granulocytic leukaemia","volume":"2","author":"Gratwohl","year":"1985","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0132_RF31","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1182\/blood.V86.5.2028.bloodjournal8652028","article-title":"A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia","volume":"86","author":"Kalhs","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF32","first-page":"1615","article-title":"Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemia","volume":"10","author":"Richard","year":"1996","journal-title":"Leukemia"},{"key":"10.1054\/blre.2000.0132_RF33","first-page":"499","article-title":"Splenectomy in the chronic myeloproliferative syndromes. A retrospective risk-versus-benefit analysis","volume":"81","author":"Jacobs","year":"1992","journal-title":"S Afr Med J"},{"key":"10.1054\/blre.2000.0132_RF34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5694\/j.1326-5377.1970.tb116870.x","article-title":"The dangers of surgery in uncontrolled haemorrhagic thrombocythaemia","volume":"1","author":"Ravich","year":"1970","journal-title":"Med J Aust"},{"key":"10.1054\/blre.2000.0132_RF35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1994.tb04744.x","article-title":"Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis","volume":"86","author":"Wang","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF36","first-page":"79","article-title":"The evolution into and the treatment of late stage polycythemia vera","volume":"13","author":"Silverstein","year":"1976","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2000.0132_RF37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10428199409049664","article-title":"Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis-a histomorphometric study on sequential trephine biopsies","volume":"14","author":"Thiele","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2000.0132_RF38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002770050474","article-title":"Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis","volume":"78","author":"Kvasnicka","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2000.0132_RF39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcp\/89.1.69","article-title":"Splenic hematopoiesis in polycythemia vera. A morphologic and immunohistologic study","volume":"89","author":"Wolf","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2000.0132_RF40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.1997.782714.x","article-title":"Identification of \u2018short-lived\u2019 and \u2018long-live\u2019 patients at presentation of idiopathic myelofibrosis","volume":"97","author":"Cervantes","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF42","first-page":"2831","volume":"93","author":"Guardiola","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976\u20131995","volume":"61","author":"Mesa","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2000.0132_RF44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/1097-0142(19820115)49:2<308::AID-CNCR2820490217>3.0.CO;2-4","article-title":"Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival","volume":"49","author":"Besa","year":"1982","journal-title":"Cancer"},{"key":"10.1054\/blre.2000.0132_RF45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO;2-8","article-title":"Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy","volume":"83","author":"Gilbert","year":"1998","journal-title":"Cancer"},{"key":"10.1054\/blre.2000.0132_RF46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<239::AID-AJH5>3.0.CO;2-Z","article-title":"Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases","volume":"53","author":"Levy","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2000.0132_RF47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/10428199509059658","article-title":"The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update","volume":"19","author":"Sacchi","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2000.0132_RF48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1991.tb07989.x","article-title":"Management of myelofibrosis with intermittent hydroxyurea","volume":"77","author":"Manoharan","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","article-title":"Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia","volume":"103","author":"Elliott","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF50","first-page":"253","article-title":"Chronic non-leukaemic myelosis","volume":"6","author":"Hicklin","year":"1937","journal-title":"Q J Med"},{"key":"10.1054\/blre.2000.0132_RF51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM195302052480601","article-title":"Splenectomy for myeloid metaplasia of the spleen","volume":"248","author":"Green","year":"1953","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0132_RF52","first-page":"106","article-title":"Splenectomy for agnogenic myeloid metaplasia","volume":"125","author":"Gomes","year":"1967","journal-title":"Surg Gynecol Obstet"},{"key":"10.1054\/blre.2000.0132_RF53","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.0954-6820.1964.tb00605.x","article-title":"Splenectomy in myelofibrosis","volume":"175","author":"Jensen","year":"1964","journal-title":"Acta Med Scand"},{"key":"10.1054\/blre.2000.0132_RF54","first-page":"550","article-title":"Splenectomy and myelofibrosis","volume":"50","author":"Jacobs","year":"1976","journal-title":"S Afr Med J"},{"key":"10.1054\/blre.2000.0132_RF55","first-page":"211","article-title":"Splenectomy in myelofibrosis and myeloid metaplasia","volume":"87","author":"Chaimoff","year":"1974","journal-title":"[Hebrew] Harefuah"},{"key":"10.1054\/blre.2000.0132_RF56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/jama.1974.03230170040012","article-title":"Sex, splenectomy, and myeloid metaplasia","volume":"227","author":"Silverstein","year":"1974","journal-title":"JAMA"},{"key":"10.1054\/blre.2000.0132_RF57","first-page":"1187","article-title":"Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen","volume":"48","author":"Dechavanne","year":"1972","journal-title":"[French] Sem Hop"},{"key":"10.1054\/blre.2000.0132_RF58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0002-9610(71)90332-1","article-title":"Splenectomy for massive splenomegaly due to myeloid metaplasia","volume":"122","author":"Morgenstern","year":"1971","journal-title":"Am J Surg"},{"key":"10.1054\/blre.2000.0132_RF59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archsurg.1970.01340260242036","article-title":"Splenectomy for hematologic disorders","volume":"101","author":"Schwartz","year":"1970","journal-title":"Arch Surg"},{"key":"10.1054\/blre.2000.0132_RF60","first-page":"336","article-title":"Subtotal splenectomy in myelofibrosis","volume":"60","author":"Morgenstern","year":"1966","journal-title":"Surgery"},{"key":"10.1054\/blre.2000.0132_RF61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2141.1977.tb00602.x","article-title":"Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis","volume":"35","author":"Mulder","year":"1977","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00000658-197801000-00006","article-title":"Splenectomy in myeloid metaplasia","volume":"187","author":"Cabot","year":"1978","journal-title":"Ann Surg"},{"key":"10.1054\/blre.2000.0132_RF63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2141.1979.tb01125.x","article-title":"Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases","volume":"42","author":"Benbassat","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood.V53.3.515.515","article-title":"Splenectomy in myeloid metaplasia","volume":"53","author":"Silverstein","year":"1979","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF65","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ajcp\/74.5.693","article-title":"Polycythemia vera with myelofibrosis and myeloid metaplasia. Acute hepatic failure following splenectomy","volume":"74","author":"McBrine","year":"1980","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2000.0132_RF66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ajh.2830330210","article-title":"The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia","volume":"33","author":"Benbassat","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2000.0132_RF67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000207177","article-title":"\u2018Early\u2019 splenectomy and survival in agnogenic myeloid metaplasia. An analysis of 338 cases published since 1940","volume":"65","author":"Benbassat","year":"1981","journal-title":"Acta Haematol"},{"key":"10.1054\/blre.2000.0132_RF68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6109(16)42337-6","article-title":"Splenectomy for hematologic disease","volume":"61","author":"Schwartz","year":"1981","journal-title":"Surg Clin North Am"},{"key":"10.1054\/blre.2000.0132_RF69","first-page":"561","article-title":"Splenectomy for agnogenic myeloid metaplasia","volume":"154","author":"Coon","year":"1982","journal-title":"Surg Gynceol Obstet"},{"key":"10.1054\/blre.2000.0132_RF70","first-page":"66","article-title":"Splenectomy for myelofibrosis","volume":"14","author":"Jarvinen","year":"1982","journal-title":"Ann Clin Res"},{"key":"10.1054\/blre.2000.0132_RF71","first-page":"80","article-title":"Splenectomy in primary myelofibrosis: two long-term survivors after splenectomy","volume":"47","author":"Yonemitsu","year":"1984","journal-title":"Nippon Ketsueki Gakkai Zasshi"},{"key":"10.1054\/blre.2000.0132_RF72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2257.1985.tb00044.x","article-title":"Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disorders","volume":"7","author":"Kesteven","year":"1985","journal-title":"Clin Lab Haematol"},{"key":"10.1054\/blre.2000.0132_RF73","first-page":"415","article-title":"Increased platelet aggregation following splenectomy in patients with myeloproliferative disease","volume":"21","author":"Aviram","year":"1985","journal-title":"Isr J Med Sci"},{"key":"10.1054\/blre.2000.0132_RF74","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF01655278","article-title":"Splenectomy for myeloproliferative disorders","volume":"9","author":"Wilson","year":"1985","journal-title":"World J Surg"},{"key":"10.1054\/blre.2000.0132_RF75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0609.1986.tb01778.x","article-title":"Effect of splenectomy on circulating haematopoietic progenitors in myelofibrosis","volume":"37","author":"Partanen","year":"1986","journal-title":"Scand J Haematol"},{"key":"10.1054\/blre.2000.0132_RF76","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/bjs.1800730915","article-title":"Early postoperative course following elective splenectomy in haematological diseases: a high complication rate in patients with myeloproliferative disorders","volume":"73","author":"Malmaeus","year":"1986","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2000.0132_RF77","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1001\/archinte.1988.00380110129028","article-title":"Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases","volume":"148","author":"Brenner","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1054\/blre.2000.0132_RF78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archsurg.1988.01400270109017","article-title":"Splenectomy for thrombocytopenia due to secondary hypersplenism","volume":"123","author":"Coon","year":"1988","journal-title":"Arch Surg"},{"key":"10.1054\/blre.2000.0132_RF79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ajh.2830330210","article-title":"The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia","volume":"33","author":"Benbassat","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2000.0132_RF80","first-page":"3630","article-title":"Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid With Myeloid Metaplasia","volume":"91","author":"Barosi","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF81","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9343(87)90091-X","article-title":"Massive hepatomegaly following splenectomy for myeloid metaplasia. Case report and review of the literature","volume":"82","author":"Towell","year":"1987","journal-title":"Am J Med"},{"key":"10.1054\/blre.2000.0132_RF82","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000204888","article-title":"Liver dysfunction following splenectomy in idiopathic myelofibrosis: a study of 10 patients","volume":"85","author":"Lopez-Guillermo","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1054\/blre.2000.0132_RF83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1988.tb02507.x","article-title":"A prognostic classification of myelofibrosis with myeloid metaplasia","volume":"70","author":"Barosi","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2141.1990.tb02609.x","article-title":"Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients","volume":"75","author":"Visani","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2000.0132_RF85","first-page":"200","article-title":"Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction","volume":"7","author":"Barosi","year":"1993","journal-title":"Leukemia"},{"key":"10.1054\/blre.2000.0132_RF86","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1182\/blood.V95.7.2226","article-title":"Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients","volume":"95","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF87","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(87)90782-3","article-title":"Splenectomy in Hodgkin\u2019s disease and second leukaemias (letter)","volume":"2","author":"van Leeuwen","year":"1987","journal-title":"Lancet"},{"key":"10.1054\/blre.2000.0132_RF88","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1993.11.5.925","article-title":"Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin\u2019s disease","volume":"11","author":"Tura","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1054\/blre.2000.0132_RF89","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V84.4.1209.1209","article-title":"Second primary cancers in patients continuously disease-free from Hodgkin\u2019s disease: a protective role for the spleen?","volume":"84","author":"Dietrich","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF90","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM199310143291603","article-title":"Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party","volume":"329","author":"Socie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2000.0132_RF91","first-page":"2132","article-title":"Splenectomy in agnogenic myeloid metaplasia (letter)","volume":"93","author":"Porcu","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF92","first-page":"115a","article-title":"Clinical correlates of splenic histopathology in myelofibrosis with myeloid metaplasia (abstract)","volume":"94 Suppl 1","author":"Mesa","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2000.0132_RF93","first-page":"359","article-title":"Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases","volume":"36","author":"Lafaye","year":"1994","journal-title":"Nouv Rev Fr Hematol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X00901322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X00901322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:15:31Z","timestamp":1682140531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X00901322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0268960X00901322"],"URL":"https:\/\/doi.org\/10.1054\/blre.2000.0132","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}